Nancy L. Shapiro

2.7k total citations
51 papers, 1.1k citations indexed

About

Nancy L. Shapiro is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Nancy L. Shapiro has authored 51 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cardiology and Cardiovascular Medicine, 17 papers in Internal Medicine and 10 papers in Surgery. Recurrent topics in Nancy L. Shapiro's work include Atrial Fibrillation Management and Outcomes (18 papers), Venous Thromboembolism Diagnosis and Management (17 papers) and Pharmacogenetics and Drug Metabolism (8 papers). Nancy L. Shapiro is often cited by papers focused on Atrial Fibrillation Management and Outcomes (18 papers), Venous Thromboembolism Diagnosis and Management (17 papers) and Pharmacogenetics and Drug Metabolism (8 papers). Nancy L. Shapiro collaborates with scholars based in United States, Belgium and China. Nancy L. Shapiro's co-authors include Edith A. Nutescu, Larisa H. Cavallari, Shitalben Patel, Kathryn M. Momary, Peter West, Marlos A. G. Viana, Taimour Langaee, Marios A. G. Viana, Susan P. Bruce and Julie A. Johnson and has published in prestigious journals such as Blood, Clinical Pharmacology & Therapeutics and American Journal of Tropical Medicine and Hygiene.

In The Last Decade

Nancy L. Shapiro

48 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy L. Shapiro United States 19 405 364 196 158 140 51 1.1k
Caroline Samer Switzerland 28 832 2.1× 406 1.1× 140 0.7× 152 1.0× 199 1.4× 107 2.5k
Lynette Swartz United States 6 233 0.6× 262 0.7× 129 0.7× 95 0.6× 56 0.4× 6 990
Samuel G. Johnson United States 18 532 1.3× 223 0.6× 80 0.4× 92 0.6× 261 1.9× 36 1.3k
Simon de Denus Canada 24 231 0.6× 1.1k 3.0× 147 0.8× 180 1.1× 383 2.7× 96 1.9k
Li Liang China 23 136 0.3× 962 2.6× 250 1.3× 79 0.5× 228 1.6× 61 2.4k
Stefan Russmann Switzerland 26 499 1.2× 125 0.3× 60 0.3× 87 0.6× 206 1.5× 64 2.2k
Surakit Nathisuwan Thailand 19 125 0.3× 403 1.1× 99 0.5× 103 0.7× 159 1.1× 72 1.2k
Sony Tuteja United States 20 283 0.7× 229 0.6× 53 0.3× 92 0.6× 320 2.3× 71 1.3k
Judy W.M. Cheng United States 21 89 0.2× 619 1.7× 83 0.4× 146 0.9× 264 1.9× 91 1.4k
Tom Schalekamp Netherlands 17 1.0k 2.5× 325 0.9× 89 0.5× 179 1.1× 101 0.7× 28 1.7k

Countries citing papers authored by Nancy L. Shapiro

Since Specialization
Citations

This map shows the geographic impact of Nancy L. Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy L. Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy L. Shapiro more than expected).

Fields of papers citing papers by Nancy L. Shapiro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy L. Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy L. Shapiro. The network helps show where Nancy L. Shapiro may publish in the future.

Co-authorship network of co-authors of Nancy L. Shapiro

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy L. Shapiro. A scholar is included among the top collaborators of Nancy L. Shapiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy L. Shapiro. Nancy L. Shapiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ou, S.‐H.I., et al.. (2023). Aspirin deprescribing in patients on oral anticoagulation for atrial fibrillation or venous thromboembolism: A national survey of clinician practices. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 6(7). 690–700. 2 indexed citations
2.
3.
Schumacher, Christie, et al.. (2020). Medication access: Policy and practice opportunities for pharmacists. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 4(1). 113–125. 6 indexed citations
4.
Shapiro, Nancy L., Hsiang‐Wen Lin, & Alan H. Lau. (2020). Creation and delivery of a clinical pharmacy practice and education program for international participants in the United States. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 3(5). 913–919.
5.
6.
Sorensen, Todd D., Nancy L. Shapiro, Neal Benedict, et al.. (2016). Recommendations for Aligning PGY2 Pharmacy Residency Training and Pharmacy Specialist Board Certification. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 36(5). e34–9. 3 indexed citations
7.
Liu, Yong, Harumi Takahashi, Katarzyna Drozda, et al.. (2012). Decreased Warfarin Clearance Associated With the CYP2C9 R150H (*8) Polymorphism. Clinical Pharmacology & Therapeutics. 91(4). 660–665. 69 indexed citations
8.
Shapiro, Nancy L., et al.. (2011). Dosing and Monitoring of Low‐Molecular‐Weight Heparin in High‐Risk Pregnancy: Single‐Center Experience. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(7). 678–685. 25 indexed citations
9.
Cavallari, Larisa H., Minoli A. Perera, Mia Wadelius, et al.. (2011). Association of the GGCX (CAA)16/17 repeat polymorphism with higher warfarin dose requirements in African Americans. Pharmacogenetics and Genomics. 22(2). 152–158. 23 indexed citations
10.
Smith, Kelly M., Todd D. Sorensen, Paul P. Dobesh, et al.. (2010). Value of Conducting Pharmacy Residency Training—The Organizational Perspective. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(12). 1313–1313. 29 indexed citations
11.
Cavallari, Larisa H., Taimour Langaee, Kathryn M. Momary, et al.. (2010). Genetic and Clinical Predictors of Warfarin Dose Requirements in African Americans. Clinical Pharmacology & Therapeutics. 87(4). 459–464. 150 indexed citations
12.
Shapiro, Nancy L.. (2007). Patient barriers and solutions for INR self-testing. Journal of Thrombosis and Thrombolysis. 25(1). 14–15. 3 indexed citations
13.
Lodolce, Amy E., et al.. (2006). Interaction Between Warfarin and Cranberry Juice. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(9). 1314–1319. 43 indexed citations
14.
Nutescu, Edith A., et al.. (2006). Warfarin and its interactions with foods, herbs and other dietary supplements. Expert Opinion on Drug Safety. 5(3). 433–451. 103 indexed citations
15.
Nutescu, Edith A., et al.. (2006). New Anticoagulant Agents: Direct Thrombin Inhibitors. Clinics in Geriatric Medicine. 22(1). 33–56. 11 indexed citations
16.
Nutescu, Edith A., et al.. (2005). A pharmacologic overview of current and emerging anticoagulants.. Cleveland Clinic Journal of Medicine. 72(Suppl_1). S2–S2. 40 indexed citations
17.
Nutescu, Edith A. & Nancy L. Shapiro. (2003). Ezetimibe: A Selective Cholesterol Absorption Inhibitor. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(11). 1463–1474. 84 indexed citations
18.
Huang, Rulin & Nancy L. Shapiro. (2000). Adenotonsillar Enlargement in Pediatric Patients Following Solid Organ Transplantation. Archives of Otolaryngology - Head and Neck Surgery. 126(2). 159–159. 21 indexed citations
19.
Salsberry, Pamela J., et al.. (1999). Self‐Reported Health Status of Low‐Income Mothers. Image the Journal of Nursing Scholarship. 31(4). 375–380. 10 indexed citations
20.
Shapiro, Nancy L. & G.O. Barbezat. (1964). A CASE OF ACUTE IRON POISONING TREATED WITH DESFERRIOXAMINE B.. PubMed. 38. 461–3. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caroline Samer Breakdown of academic impact, for papers by Lynette Swartz Breakdown of academic impact, for papers by Samuel G. Johnson Breakdown of academic impact, for papers by Simon de Denus Breakdown of academic impact, for papers by Li Liang Breakdown of academic impact, for papers by Stefan Russmann Breakdown of academic impact, for papers by Surakit Nathisuwan Breakdown of academic impact, for papers by Sony Tuteja Breakdown of academic impact, for papers by Judy W.M. Cheng Breakdown of academic impact, for papers by Tom Schalekamp
Rankless by CCL
2026